Angina

• FDA approval · 2020-08-18
  FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' supplemental application for ranolazine, enabling a generic version of the heart medicine to be marketed…

• FDA approval · 2020-03-23
  FDA Approved: RANOLAZINE — Original Application (SunGen Pharma LLC)

  FDA approves SunGen Pharma LLC's original application for a generic ranolazine product (Ranolazine) to treat chronic angina.

• FDA approval · 2020-03-15
  FDA Approved: RANOLAZINE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for ranolazine submitted by Actavis Pharma, Inc.

• FDA approval · 2020-02-25
  FDA Approved: RANOLAZINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  FDA approved Lupin Pharmaceuticals' supplemental application to market a generic Ranolazine product. This approval pertains to a generic ver…

• FDA approval · 2020-02-24
  FDA Approved: RANOLAZINE — Supplemental Application (Ajanta Pharma USA Inc.)

  FDA approved a supplemental application for Ranolazine from Ajanta Pharma USA Inc., enabling updated labeling for the generic product.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2019-10-31
  FDA Approved: RANOLAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for ranolazine under Sun Pharmaceutical Industries’ ANDA211707. This approval updates the status of …

• FDA approval · 2019-05-28
  FDA Approved: RANOLAZINE — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries' generic ranolazine under an original application, expanding access to this antianginal therapy f…